alexa Modification of Biochemical Derangements and VEGF Secretion May Prevent Diabetic Retinopathy (DR) | OMICS International| Abstract
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • Clin Exp Ophthalmol 2019, Vol 10(3): 803

Modification of Biochemical Derangements and VEGF Secretion May Prevent Diabetic Retinopathy (DR)

Lakshmi Kanta Mondal1*, Subhasish Pramanik2, Sriparna De3, Suman K Paine4 and Gautam Bhaduri5
1Regional Institute of Ophthalmology, Kolkata, India
2Institute of Post-Graduate Medical Education & Research, Kolkata, India
3Department of Polymer Science and Technology, University of Calcutta, Kolkata, India
4Regional Medical Research Centre ICMR, Dibrugarh, India
5MGM Medical College, Kissangang, Bihar, India
*Corresponding Author : Lakshmi Kanta Mondal, Regional Institute of Ophthalmology, Kolkata, India, Email: [email protected]

Received Date: Feb 21, 2019 / Accepted Date: May 15, 2019 / Published Date: May 22, 2019


Unutilized, enormous intracellular glucose in insulin-nondependent tissues, including retina, leads to several consequences: (i) increased formation of advanced glycation end products, (ii) activation of polyol pathway, (iii) anaerobic glycolysis, (iv) glutamate toxicity, (v) lipid peroxidation and oxidative stress, and all of these, finally, resulting in convergence to up regulation of antigenic VEGF and VEGFR2, the crucial player in the development of DR. The purpose of the present pilot study is to assess the effects of one kind of intervention on the development of DR: supplementation of B-vitamins (B1, B2, B3, B5 and B6), vitamin C and vitamin E on amelioration of biochemical derangements related to development of DR.

400 diagnosed type 2 diabetic patients were identified for the study, of which subjects were randomised 1:1 to receive oral antidiabetic medication along with B-vitamins, vitamin C and vitamin E or only antidiabetic medication to give the study and controlled population in this unblended randomized trial since December 2004 to December 2017. The following preliminary tasks were completed: firstly, baseline detailed fundoscopic examinations were enough to exclude the presence of retinopathy. Secondly, had baseline biochemical parameters like bllod concentration of NAD+, NADH, advanced glycation end products (AGEs), malondialdehyde (MDA), VEGF and VEGFR2 determined? Lastly, yearly fundoscopic examinations were documented to detect the features of DR.

These efforts revealed the following findings: 32 among 187 (17.11%) patients who received supplementation with B-vitamins, vitamin C and vitamin E developed very mild microangiopathy; whereas 92 patients among 200 (46%) controlled ones developed mild to moderate non proliferative diabetic retinopathy (NPDR). 13 patients of the study group who didn’t follow up were counted as lost from the observation of the study.

The findings lead to this conclusion: Glycolysis and citric acid cycle should run uninterruptedly by supplementation of precursors of oxidized cofactors and antioxidants to prevent biochemical derangements which lead to increased expression of VEGF.

Keywords: Type 2 Diabetes Mellitus (T2DM); Diabetic Retinopathy (DR); Vitamin B; Vitamin C; Vitamin E; Biochemical derangement; Nicotinamide Adenine Dinucleotide Positive (NAD+), Reduced Nicotinamide Adenine Dinucleotide (NADH); Red Blood Cell (RBC)

Citation: Mondal LK, Pramanik S, De S, Paine SK, Bhaduri G (2019) Modification of Biochemical Derangements and VEGF Secretion may Prevent Diabetic Retinopathy (DR) . J Clin Exp Ophthalmol 10: 803.

Copyright: © 2019 Mondal LK, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.